Loading page…
Healthcare
BeOne Medicines Ltd. achieves an AlphaScore of 65/100 within the healthcare sector. Important financial metrics include a high revenue growth rate of 40.23% and a gross margin of 87.49%. A primary strength is its exceptional growth subscore of 97, driven by robust top-line expansion. A notable risk is the elevated price-to-earnings ratio of 63.41, which signals premium valuation pricing. Evidence is limited strictly to the provided snapshot date of October 11, 2026.
Written 11/10/2026, 00:31:51 UTC · Snapshot 11/10/2026